All articles by Sarah Houlton – Page 6

Careers
Allow me to demonstrate

2012-12-05T00:00:00Z

As Peter Wothers gets ready to deliver this year’s Royal Institution Christmas lectures, Sarah Houlton finds out he’s had a lifetime of preparation
Careers
Nobel signals for new drugs

2012-11-08T00:00:00Z

Sarah Houlton talks to a company that’s capitalising on the chemistry of communication
News
EU tightens drug rules in wake of Mediator scandal

2012-09-19T00:00:00Z

Withdrawal of a drug in one EU member state will trigger an alert throughout the rest
News
Drug maker apologises for thalidomide tragedy

2012-09-04T00:00:00Z

Fifty years after the event Grünenthal issues an apology as victims of the drug continue to press for compensation
Feature
Fast, flexible and flourishing

2012-08-22T00:00:00Z

Paul Workman’s experiences in big pharma, academia and biotech gave him the tools to develop new drugs and spin out successful companies. Sarah Houlton profiles the 2012 Chemistry World entrepreneur of the year
Careers
Succouring success

2012-07-05T00:00:00Z

Sarah Houlton reports on BioCity Nottingham, a start-up incubator helping fledgling companies find their feet
Business
Roche rapped for side-effect reporting failure

2012-06-26T00:00:00Z

European medicines regulator names and shames Swiss giant for not disclosing 80,000 instances of potential adverse drug reactions
Feature
Feeding a growing world

2012-06-06T00:00:00Z

Pesticides play a vital role in food production. So do they really deserve their tarnished public image? Sarah Houlton investigates
News
HDL drug class struggling after latest flop

2012-05-28T11:59:00Z

The failure of another 'good' cholesterol-raising drug and a new genetic study casts shadow over HDL hypothesis
Business
HDL drug class struggling after latest flop

2012-05-27T00:00:00Z

The failure of another ‘good’ cholesterol-raising drug and a new genetic study casts shadow over HDL hypothesis
Business
AstraZeneca seeks to refill dry pipeline with gout drug

2012-04-26T00:00:00Z

UK pharma giant splashes out $1.26 billion on US gout specialist Ardea Biosciences
Careers
Educating scholars

2012-03-31T00:00:00Z

With many universities now opting to employ dedicated teaching staff, Sarah Houlton meets two of them for a lesson in undergraduate chemistry
News
Illumina fends off Roche hostile bid

2012-01-27T13:49:00Z

Roche aims to expand personalised medicine diagnostics by acquiring the gene sequencing leader
Careers
Managing change: Patent protectors

2012-01-27T10:34:13Z

When it comes to the world of patents, a chemist's knowledge of the laws of the lab can be as important as knowing the laws of the land, as Sarah Houlton finds out
News
Takeda slashes 10% of its workforce

2012-01-20T13:26:00Z

Japanese pharmaceutical firm sheds 2800 jobs in the US and Europe after recent takeover of Nycomed
Feature
Chasing the wave

2011-12-22T12:24:00Z

With the authorities, medics and analytical chemists struggling to break the flow of new legal highs, the bad guys appear to be getting the upper hand. Sarah Houlton reports
News
Pharma braces for patent cliff impact

2011-12-22T11:45:00Z

Lipitor patent expires while familiar problems persist
News
Academia grows its role in drug discovery

2011-12-08T12:36:00Z

Report claims patents filed by universities around the world are growing rapidly while pharma patents are stagnating
News
A shot in the arm for drugs for neglected diseases

2011-11-01T15:00:00Z

Intellectual property sharing database will give researchers new leads in the fight against TB and malaria
News
Graphene and zeolite team up for catalysis

2011-10-27T14:42:00Z

Graphene enhances the photocatalytic activity of zeolites